Coronary bypass and carotid endarterectomy: does a combined approach increase risk? A metaanalysis

M A Borger1, S E Fremes, R D Weisel

  • 1Division of Cardiovascular Surgery, The Toronto Hospital, Ontario, Canada.

Insights

Performing combined coronary artery bypass grafting and carotid endarterectomy surgery increases the risk of stroke or death compared to staged procedures. Further randomized trials are needed to confirm the optimal management strategy for patients with both conditions.

Area of Science:

  • Cardiovascular Surgery
  • Neurosurgery
  • Medical Decision Making

Background:

  • Patients with concurrent carotid artery disease and coronary artery disease face a complex surgical decision.
  • The choice lies between combined procedures under a single anesthetic or staged, separate surgeries.

Purpose of the Study:

  • To compare stroke and mortality rates between combined and staged surgical approaches for patients with concomitant carotid and coronary artery disease.

Main Methods:

  • A systematic literature review and meta-analysis of peer-reviewed studies comparing combined versus staged coronary artery bypass grafting and carotid endarterectomy.
  • Outcomes analyzed included stroke, death, and the composite endpoint of stroke or death using the Mantel-Haenszel method.

Main Results:

  • Sixteen studies involving 844 combined and 920 staged patients were analyzed. None were fully randomized.
  • Combined procedures showed a significantly increased risk of stroke or death (RR 1.49; p=0.034).
  • Trends indicated higher risks for stroke (p=0.068) and death (p=0.084) in the combined group, with crude event rates for stroke or death at 9.5% vs. 5.7%.

Conclusions:

  • Combined coronary artery bypass grafting and carotid endarterectomy may carry a higher risk of stroke or death compared to staged procedures.
  • A definitive randomized trial is necessary to establish the optimal treatment strategy for this patient population.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...